Nahdi Medical Company
Saudi Stock Exchange 4164.SR
Nahdi Medical Company Price to Earnings Ratio (P/E) on January 14, 2025: 17.37
-
Nahdi Medical Company 52-week high Price to Earnings Ratio (P/E) is 22.32 on March 25, 2024, which is 28.48% above the current Price to Earnings Ratio (P/E).
-
Nahdi Medical Company 52-week low Price to Earnings Ratio (P/E) is 16.81 on November 27, 2024, which is -3.24% below the current Price to Earnings Ratio (P/E).
-
Nahdi Medical Company average Price to Earnings Ratio (P/E) for the last 52 weeks is 19.19.
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
| CEO | Mr. Yasser Ghulam Bin Abdulaziz Joharji |
| IPO Date | April 18, 2022 |
| Location | Saudi Arabia |
| Headquarters | Abraq Al-Roghamah District |
| Employees | 5,169 |
| Sector | Health Care |
| Industries | |
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as medicine, wellness, mom and baby, beauty, and other FMCG products. It also provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. In addition, the company engages in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It operates approximately 1,151 pharmacies. The company was founded in 1986 and is headquartered in Jeddah, the Kingdom of Saudi Arabia. Nahdi Medical Company operates as a subsidiary of Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Past 5 years
USD 20.64
USD 313.79
USD 17.42
USD 78.21
USD 106.72
StockViz Staff
January 15, 2025
Any question? Send us an email